Intuitive Surgical (NASDAQ:ISRG) Upgraded by Citigroup to Buy Rating

Citigroup upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a neutral rating to a buy rating in a report issued on Wednesday morning, Marketbeat Ratings reports. They currently have $590.00 price objective on the medical equipment provider’s stock.

A number of other research analysts also recently issued reports on the stock. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Raymond James Financial increased their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. HSBC raised their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 19th. Finally, Wells Fargo & Company upped their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Intuitive Surgical Trading Up 1.4%

ISRG stock opened at $492.87 on Wednesday. The firm has a market cap of $175.03 billion, a P/E ratio of 62.47, a P/E/G ratio of 3.75 and a beta of 1.66. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $603.88. The stock’s 50 day simple moving average is $516.79 and its 200 day simple moving average is $512.60.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. The firm’s revenue was up 18.8% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 645 shares of the business’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the transaction, the senior vice president owned 1,613 shares of the company’s stock, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 37,907 shares of company stock valued at $19,997,187 in the last quarter. 0.70% of the stock is owned by insiders.

Institutional Trading of Intuitive Surgical

A number of institutional investors have recently made changes to their positions in ISRG. Riversedge Advisors LLC raised its stake in Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after acquiring an additional 17 shares in the last quarter. Prosperity Consulting Group LLC boosted its stake in shares of Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares in the last quarter. Fiduciary Financial Group LLC boosted its stake in shares of Intuitive Surgical by 2.1% in the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 19 shares in the last quarter. Rossmore Private Capital grew its holdings in shares of Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after purchasing an additional 20 shares during the last quarter. Finally, Activest Wealth Management grew its holdings in shares of Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Citi upgraded ISRG to Buy and set a $590 price target, calling out resilient med‑tech fundamentals — a clear near‑term catalyst that likely pushed buying interest. Read More.
• Positive Sentiment: Analyst coverage and commentary emphasize product momentum (da Vinci 5, Ion and SP platforms) and procedure growth, supporting revenue and recurring‑revenue visibility into 2026. Read More.
• Positive Sentiment: Intuitive closed the acquisition of regional da Vinci and Ion distribution businesses, consolidating distribution and potentially improving margin/recurring revenue capture. Read More.
• Neutral Sentiment: Seeking Alpha reiterated the company’s strong moat and solid Q4 results but flagged valuation (P/E ~63 vs. historical ~53) and recommended a Hold — this tempers upside for value‑oriented investors. Read More.
• Neutral Sentiment: MarketWatch noted ISRG outperformed peers on a strong trading day, reflecting today’s buying interest but not adding new fundamental news. Read More.
• Neutral Sentiment: MarketBeat’s roundup reiterates broad analyst support and a consensus target near $616, underpinning a constructive longer‑term view but noting mixed ratings (Buy/Hold). Read More.
• Negative Sentiment: Insider selling: multiple recent sales by senior executives (SVP Mark Brosius and EVP Myriam Curet) have been disclosed; while common for compensation/liquidity reasons, clustered insider sales can weigh on sentiment. Read More.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.